Consolidation of Variable Interest Entity (Tables)

12 Months Ended

Dec. 31, 2015

Equity Method Investments And Joint Ventures [Abstract]

Pro Forma Financial Information (Unaudited)

Pro Forma Financial Information (Unaudited).

The financial information in the table below summarizes the combined results of operations of Milestone Scientific and subsidiaries and Milestone Medical Inc. (a variable interest entity) on a pro forma basis as though the companies had been combined as of the beginning of the earliest period presented. The pro forma financial information is presented for informational purposes only and is not indicative of the result of operations that would have been achieved if the consolidation had taken place at the beginning of each of the period presented.

	2015 Pro Forma Consolidated			2014Pro Forma Consolidated
Revenue	$	9,542,544		$	10,333,089
Cost of sales		3,061,299			3,630,765
Gross profit		6,481,245			6,702,324
Selling, general and administrative    expenses		12,645,445			8,899,447
Research and development    expenses		892,255			489,551
Total operating expenses		13,537,700			9,388,998
Loss income from operations		(7,056,455	)		(2,686,674	)
Other Expenses		(5,347	)		-
Interest Expense		(40,331	)		(2,955	)
Interest Income		3,838			5,057
Loss before provision for income    taxes		(7,098,295	)		(2,684,572	)
Provision for income tax		(36,157	)		(9,509	)
Loss before equity in net earnings of equity investments		(7,134,452	)		(2,694,081	)
Loss on earnings from Education Joint Venture		(7,846	)		(17,890	)
Loss on earnings from China Joint Venture		(418,432	)		(810	)
Net loss in equity investments		(426,278	)		(18,700	)
Net loss		(7,560,730	)		(2,712,781	)
Net loss attributable to the    noncontrolling interests		2,093,208			954,423
Net loss attributable to Milestone    Scientific Inc.	$	(5,467,522	)	$	(1,758,358	)